These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 20978134)

  • 41. A novel mutation in VKORC1 and its effect on enzymatic activity in Japanese warfarin-resistant rats.
    Tanaka KD; Kawai YK; Ikenaka Y; Harunari T; Tanikawa T; Fujita S; Ishizuka M
    J Vet Med Sci; 2013 Feb; 75(2):135-9. PubMed ID: 23018795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of bacterial disulfide bond formation by the anticoagulant warfarin.
    Dutton RJ; Wayman A; Wei JR; Rubin EJ; Beckwith J; Boyd D
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):297-301. PubMed ID: 20018758
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A protein oxidase catalysing disulfide bond formation is localized to the chloroplast thylakoids.
    Feng WK; Wang L; Lu Y; Wang XY
    FEBS J; 2011 Sep; 278(18):3419-30. PubMed ID: 21781282
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vitamin K epoxide reductase significantly improves carboxylation in a cell line overexpressing factor X.
    Sun YM; Jin DY; Camire RM; Stafford DW
    Blood; 2005 Dec; 106(12):3811-5. PubMed ID: 16081695
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The vitamin K cycle.
    Stafford DW
    J Thromb Haemost; 2005 Aug; 3(8):1873-8. PubMed ID: 16102054
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determination of disulfide bond assignment of human vitamin K-dependent gamma-glutamyl carboxylase by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Tie JK; Mutucumarana VP; Straight DL; Carrick KL; Pope RM; Stafford DW
    J Biol Chem; 2003 Nov; 278(46):45468-75. PubMed ID: 12963724
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Conversion of vitamin K epoxide to hydroxyvitamin K by liver microsomes from warfarin-resistant rats.
    Nutr Rev; 1983 Aug; 41(8):253-4. PubMed ID: 6355923
    [No Abstract]   [Full Text] [Related]  

  • 48. Profactor IX propeptide and glutamate substrate binding sites on the vitamin K-dependent carboxylase identified by site-directed mutagenesis.
    Sugiura I; Furie B; Walsh CT; Furie BC
    J Biol Chem; 1996 Jul; 271(30):17837-44. PubMed ID: 8663364
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The vitamin K oxidoreductase is a multimer that efficiently reduces vitamin K epoxide to hydroquinone to allow vitamin K-dependent protein carboxylation.
    Rishavy MA; Hallgren KW; Wilson LA; Usubalieva A; Runge KW; Berkner KL
    J Biol Chem; 2013 Nov; 288(44):31556-66. PubMed ID: 23918929
    [TBL] [Abstract][Full Text] [Related]  

  • 50. VKORC1 and the vitamin K cycle.
    Garcia AA; Reitsma PH
    Vitam Horm; 2008; 78():23-33. PubMed ID: 18374188
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dicoumarol: A Drug which Hits at Least Two Very Different Targets in Vitamin K Metabolism.
    Timson DJ
    Curr Drug Targets; 2017; 18(5):500-510. PubMed ID: 26201483
    [TBL] [Abstract][Full Text] [Related]  

  • 52. VKOR paralog VKORC1L1 supports vitamin K-dependent protein carboxylation in vivo.
    Lacombe J; Rishavy MA; Berkner KL; Ferron M
    JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The vitamin K cycle.
    Oldenburg J; Marinova M; Müller-Reible C; Watzka M
    Vitam Horm; 2008; 78():35-62. PubMed ID: 18374189
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vitamin K epoxide and quinone reductase activities. Evidence for reduction by a common enzyme.
    Gardill SL; Suttie JW
    Biochem Pharmacol; 1990 Sep; 40(5):1055-61. PubMed ID: 2390102
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Warfarin traps human vitamin K epoxide reductase in an intermediate state during electron transfer.
    Shen G; Cui W; Zhang H; Zhou F; Huang W; Liu Q; Yang Y; Li S; Bowman GR; Sadler JE; Gross ML; Li W
    Nat Struct Mol Biol; 2017 Jan; 24(1):69-76. PubMed ID: 27918545
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The membrane topology of vitamin K epoxide reductase is conserved between human isoforms and the bacterial enzyme.
    Cao Z; van Lith M; Mitchell LJ; Pringle MA; Inaba K; Bulleid NJ
    Biochem J; 2016 Apr; 473(7):851-8. PubMed ID: 26772871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vitamin K-dependent carboxylase. Possible role for thioredoxin in the reduction of vitamin K metabolites in liver.
    Johan L; van Haarlem M; Soute BA; Vermeer C
    FEBS Lett; 1987 Oct; 222(2):353-7. PubMed ID: 3308517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of buried charged groups on cysteine thiol ionization and reactivity in Escherichia coli thioredoxin: structural and functional characterization of mutants of Asp 26 and Lys 57.
    Dyson HJ; Jeng MF; Tennant LL; Slaby I; Lindell M; Cui DS; Kuprin S; Holmgren A
    Biochemistry; 1997 Mar; 36(9):2622-36. PubMed ID: 9054569
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vitamin K epoxide reductase contributes to protein disulfide formation and redox homeostasis within the endoplasmic reticulum.
    Rutkevich LA; Williams DB
    Mol Biol Cell; 2012 Jun; 23(11):2017-27. PubMed ID: 22496424
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of sequences within the gamma-carboxylase that represent a novel contact site with vitamin K-dependent proteins and that are required for activity.
    Pudota BN; Hommema EL; Hallgren KW; McNally BA; Lee S; Berkner KL
    J Biol Chem; 2001 Dec; 276(50):46878-86. PubMed ID: 11591726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.